Sight Sciences' (SGHT) Neutral Rating Reiterated at Piper Sandler

Piper Sandler restated their neutral rating on shares of Sight Sciences (NASDAQ:SGHT – Free Report) in a research report released on Friday, Benzinga reports. The brokerage currently has a $6.00 target price on the stock, up from their previous target price of $5.00. Separately, Needham & Company LLC reaffirmed a hold rating on shares of […]

Related Keywords

Alison Bauerlein ,Piper Sandler ,Paul Badawi ,Needham Company ,Sight Sciences ,Analyst Recommendations For Sight Sciences ,Sight Sciences Company Profile ,Mirae Asset Global Investments Co ,Sight Sciences Inc ,News Ratings For Sight Sciences Daily ,Jackson Square Partners ,Sight Sciences Price Performance ,Securities Exchange Commission ,Tower Research Capital ,Free Report ,Get Free Report ,Exchange Commission ,Asset Global Investments ,Research Capital ,Square Partners ,Surgical Glaucoma ,Sight Sciences Daily ,Nasdaq Sght ,Isght ,Medical ,Reiterated Rating ,